Despite centuries of stigmatization, the vagina is truly incredible. Among many other things, it’s the structural connection between the outside world and the female body’s most powerful reproductive organs.
So it makes sense that the vaginal microbiome — defined as the complex ecosystem of microorganisms, including bacteria and fungi, that lives inside the vagina — has biologically evolved to help protect that reproductive system.
Every day, the vaginal microbiome performs the equivalent of modern health miracles. It can fight off yeast infections and bacterial vaginosis (BV), protect a pregnancy, and possibly even defend against cancer, as well as play a crucial role in your overall health.
Microbiome research is a relatively new field, and lots of resources have been invested in understanding other human microbiomes like the one in your gut. But when it comes to your vagina, the microbiome has been overlooked.
We wish the reason why wasn’t yet another gender gap…but that’s why we’re here!
We created the Evvy Vaginal Health Test to provide you with groundbreaking insights into your own microbiome, while also elevating the vaginal microbiome to its rightful place in research and clinical care.
How does the vaginal microbiome work?
While a variety of bacteria and fungi can exist in the vagina, a type of bacteria called lactobacilli are the local heroes. Lactobacilli ensure that the vaginal environment is inhospitable for potential pathogens. These bacteria work their magic in a variety of ways:
- Creating lactic acid that helps keep the pH low, ideally between 3.8 and 4.5. (Ever taken a vaginal pH test? Measuring the acidity of your vagina is a rough metric for the presence of protective bacteria in your vaginal microbiome!)
- Taking up space on the vaginal wall and preventing other pathogens from hanging around
- Producing bacteriocins (your body’s natural antibiotic) to further inhibit the growth of disruptive bacteria
- Keeping inflammation down in the genital tract
A lack of lactobacilli in your vaginal microbiome can allow pathogens to colonize. If and when they do, that's referred to as vaginal dysbiosis.
In a state of dysbiosis, there is a high diversity of various types of bacteria, in which disruptive microbes such as Gardnerella, E.coli, or Mycoplasma can flourish.
These bacteria can then cause unwanted symptoms like itching, burning, irritation, or pain, as well as catalyze vaginal infections like BV, yeast infections, and urinary tract infections (UTIs).
Recurrent symptoms? Meet Evvy's at-home vaginal microbiome test, approved by leading OB-GYNs.
Vaginal infections and the microbiome
Unfortunately, your vaginal microbiome isn’t just home to protective microbes. The bacteria and fungi that cause vaginal infections are also part of your microbiome. When the vaginal microbiome is disrupted, it creates an opportunity for these bad microbes to thrive.
The most common vaginal infection is bacterial vaginosis (BV), an umbrella term for bacterial infections. BV is defined by high bacterial diversity and an abundance of disruptive bacteria.
One in three women will get BV each year, and up to 84% of these cases are asymptomatic. BV disproportionately affects Black and Hispanic women, with disappointingly lacking research as to why (that's one of the many things Evvy's here to change!).
Dysbiosis of the vaginal microbiome can also catalyze other types of infections, such as yeast infections, aerobic vaginitis (AV) and cytolytic vaginosis (CV), many of which can have frustrating — and confusingly similar — symptoms, such as itchiness, abnormal discharge, and burning.
If you’ve come to Evvy because you experience infections again and again - you’re not alone. Evvy was built by women who have been there! Moreover, vaginal infections are one of the largest categories of health issues that female-bodied people face. Aside from BV, 1 in 3 women will have a UTI by age 24, and 1 in 2 will experience one in their lifetime. Meanwhile, 75% of women will experience a yeast infection at least once in their lifetime.
Through testing the vaginal microbiome, we can both provide better care for those who are suffering and move the needle in furthering research to better understand and treat these conditions.
The impact of the vaginal microbiome on overall health
To add to the many reasons the vaginal microbiome deserves more attention: recent research has uncovered groundbreaking insights on the vaginal microbiome’s role in female health beyond the vagina.
It turns out that having beneficial bacteria like lactobacilli in your vaginal microbiome can protect you from a variety of other potential health outcomes. Meanwhile, disruptive microbes can create a favorable environment for other infectious microorganisms to enter, increase inflammation, and inhibit your immune response.
Research has shown that the composition of your vaginal microbiome is associated with the risk of:
- STIs such as chlamydia, gonorrhea, trichomoniasis, herpes, HPV, and HIV
- Pelvic inflammatory disease
- Fertility issues or failed IVF cycles
- Pregnancy complications such as miscarriage, preterm birth, neonatal problems, and preeclampsia
- Gynecological cancers such as ovarian, cervical, or endometrial cancer
- Toxic shock syndrome (TSS)
By knowing your individual microbial composition, you can take a proactive approach to your long-term health, as well as potentially prevent future health complications.
Not all microbiomes are the same
The level of protection and propensity for certain symptoms or health risks varies based on which Community State Type you are in. Unlike blood types, you can shift from one CST to another.
Four of the types are dominated by a specific species of lactobacilli:
- Type 1: Lactobacillus crispatus
- Type 2: Lactobacillus gasseri
- Type 3: Lactobacillus iners
- Type 5: Lactobacillus jensenii
Those who don't have a dominant species of lactobacilli are labeled as Type 4. Individuals who are experiencing vaginal dysbiosis (i.e. infections) fall into this group. However, so do some rare healthy vaginal microbiome compositions, too. For this reason, Type 4 is broken into five more subgroups that get into further specifics.
Want to know your CST?
Our Vaginal Health Test not only shows you all bacteria and fungi in your microbiome but what CST your microbiome falls into at that point in time.
While research on the types is ever-evolving, testing for your type with Evvy can provide insight into your individual bacterial composition — both now and as it changes over time. Armed with the most comprehensive data and advanced testing methods, our team can help you understand what your type means for your health!
An ecosystem in flux
Your vaginal microbiome is ever-evolving and fluctuates as other aspects of your life shift. There are multiple reasons that the vaginal microbiome changes over time, but some major contributors to this include:
Day-to-day behaviors also influence the health of the vaginal microbiome, including:
- Hormonal fluctuations
- Taking certain medications/supplements (especially antibiotics)
- Using vaginal products
Testing over time with Evvy can help correlate your habits and treatments with what’s going on in your microbiome, so you can isolate your specific triggers and take control of your vaginal health!
Testing your vaginal microbiome
Evvy’s Vaginal Health Test is the first-ever metagenomic vaginal microbiome test to help you understand and improve your vaginal health. It’s a simple, at-home swab that uncovers all bacteria and fungi present in your vaginal microbiome.
Unlike genetic results, which are static, microbiomes are dynamic and can reflect progression towards or away from disease. By testing over time, you can catch potential imbalances early, giving you the chance to proactively promote the protective bacteria and prevent the disruptive bacteria from taking hold.
And when you do change up your routine — try a new probiotic, change your birth control, etc. — we'll take the guesswork out of figuring out how it’s affecting your microbiome. By testing over time, you can see how your life and supplements are impacting your vaginal microbiome’s defense.
Referenced in this article:
1. Amabebe, Emmanuel, and Dilly OC Anumba. "Psychosocial stress, cortisol levels, and maintenance of vaginal health." Frontiers in endocrinology 9 (2018): 568.
2. Amabebe, Emmanuel, and Dilly OC Anumba. "The vaginal microenvironment: the physiologic role of lactobacilli." Frontiers in medicine 5 (2018): 181.
3. Aslan, Erdogan, and Nadia Bechelaghem. "To ‘douche’ or not to ‘douche’: hygiene habits may have detrimental effects on vaginal microbiota." Journal of Obstetrics and Gynaecology 38, no. 5 (2018): 678-681.
4. Atashili, Julius, Charles Poole, Peter M. Ndumbe, Adaora A. Adimora, and Jennifer S. Smith. "Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies." AIDS (London, England) 22, no. 12 (2008): 1493.
5. Balle, Christina, Iyaloo N. Konstantinus, Shameem Z. Jaumdally, Enock Havyarimana, Katie Lennard, Rachel Esra, Shaun L. Barnabas et al. "Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial." Nature communications 11, no. 1 (2020): 1-15.
6. Brotman, Rebecca M., Mark A. Klebanoff, Tonja R. Nansel, Kai F. Yu, William W. Andrews, Jun Zhang, and Jane R. Schwebke. "Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection." Journal of Infectious Diseases 202, no. 12 (2010): 1907-1915.
7. Brotman, Rebecca M., Xin He, Pawel Gajer, Doug Fadrosh, Eva Sharma, Emmanuel F. Mongodin, Jacques Ravel, Elbert D. Glover, and Jessica M. Rath. "Association between cigarette smoking and the vaginal microbiota: a pilot study." BMC infectious diseases 14, no. 1 (2014): 1-11.
8. "CDC - Bacterial Vaginosis Statistics". 2022. Cdc.Gov. https://www.cdc.gov/std/bv/stats.htm.
9. Champer, M., A. M. Wong, J. Champer, I. L. Brito, P. W. Messer, J. Y. Hou, and J. D. Wright. "The role of the vaginal microbiome in gynaecological cancer." BJOG: An International Journal of Obstetrics & Gynaecology 125, no. 3 (2018): 309-315.
10. Coudray, Makella S., and Purnima Madhivanan. "Bacterial vaginosis—A brief synopsis of the literature." European Journal of Obstetrics & Gynecology and Reproductive Biology 245 (2020): 143-148.
11. Denning, David W., Matthew Kneale, Jack D. Sobel, and Riina Rautemaa-Richardson. "Global burden of recurrent vulvovaginal candidiasis: a systematic review." The Lancet Infectious Diseases 18, no. 11 (2018): e339-e347.
12. DiGiulio, Daniel B., Benjamin J. Callahan, Paul J. McMurdie, Elizabeth K. Costello, Deirdre J. Lyell, Anna Robaczewska, Christine L. Sun et al. "Temporal and spatial variation of the human microbiota during pregnancy." Proceedings of the National Academy of Sciences 112, no. 35 (2015): 11060-11065.
13. Dingens, Adam S., Tessa S. Fairfortune, Susan Reed, and Caroline Mitchell. "Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study." BMC pregnancy and childbirth 16, no. 1 (2016): 1-8.
14. Edwards, Vonetta L., Steven B. Smith, Elias J. McComb, Jeanne Tamarelle, Bing Ma, Michael S. Humphrys, Pawel Gajer et al. "The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection." MBio 10, no. 4 (2019).
15. Foxman, Betsy. "Epidemiology of urinary tract infections: incidence, morbidity, and economic costs." The American journal of medicine 113, no. 1 (2002): 5-13.
16. Gillet, Evy, Joris FA Meys, Hans Verstraelen, Carolyne Bosire, Philippe De Sutter, Marleen Temmerman, and Davy Vanden Broeck. "Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis." BMC infectious diseases 11, no. 1 (2011): 1-9.
17. Gorgos, Linda M., Laura K. Sycuro, Sujatha Srinivasan, Tina L. Fiedler, Martin T. Morgan, Jennifer E. Balkus, R. Scott McClelland, David N. Fredricks, and Jeanne M. Marrazzo. "Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis." Sexually transmitted diseases 42, no. 9 (2015): 475.
18. Haggerty, Catherine L., Patricia A. Totten, Gong Tang, Sabina G. Astete, Michael J. Ferris, Johana Norori, Debra C. Bass, David H. Martin, Brandie D. Taylor, and Roberta B. Ness. "Identification of novel microbes associated with pelvic inflammatory disease and infertility." Sexually transmitted infections 92, no. 6 (2016): 441-446.
19. Koedooder, Rivka, Martin Singer, Sam Schoenmakers, Paul HM Savelkoul, Servaas A. Morré, Jonathan D. de Jonge, Linda Poort et al. "The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study." Human Reproduction 34, no. 6 (2019): 1042-1054.
20. Kosti, Idit, Svetlana Lyalina, Katherine S. Pollard, Atul J. Butte, and Marina Sirota. "Meta-analysis of vaginal microbiome data provides new insights into preterm birth." Frontiers in microbiology 11 (2020): 476
21. Koumans, Emilia H., Maya Sternberg, Carol Bruce, Geraldine McQuillan, Juliette Kendrick, Madeline Sutton, and Lauri E. Markowitz. "The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health." Sexually transmitted diseases 34, no. 11 (2007): 864-869.
22. Leitich, Harald, and Herbert Kiss. "Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome." Best practice & research Clinical obstetrics & gynaecology 21, no. 3 (2007): 375-390.
23. Lewis, Felicia MT, Kyle T. Bernstein, and Sevgi O. Aral. "Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases." Obstetrics and gynecology 129, no. 4 (2017): 643.
24. Lin, Chia-Ying, Chiao-Yun Lin, Yuan-Ming Yeh, Lan-Yan Yang, Yun-Shien Lee, Angel Chao, Chia-Yin Chin, An-Shine Chao, and Chia-Yu Yang. "Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota." Scientific reports 10, no. 1 (2020): 1-13.
25. MacPhee, Roderick A., Wayne L. Miller, Gregory B. Gloor, John K. McCormick, Jo-Anne Hammond, Jeremy P. Burton, and Gregor Reid. "Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus." Applied and environmental microbiology 79, no. 6 (2013): 1835-1842.
26. Muhleisen, Alicia L., and Melissa M. Herbst-Kralovetz. "Menopause and the vaginal microbiome." Maturitas 91 (2016): 42-50.
27. Nené, Nuno R., Daniel Reisel, Andreas Leimbach, Dorella Franchi, Allison Jones, Iona Evans, Susanne Knapp et al. "Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study." The Lancet Oncology 20, no. 8 (2019): 1171-1182.
28. Ravel, Jacques, Pawel Gajer, Zaid Abdo, G. Maria Schneider, Sara SK Koenig, Stacey L. McCulle, Shara Karlebach et al. "Vaginal microbiome of reproductive-age women." Proceedings of the National Academy of Sciences 108, no. Supplement 1 (2011): 4680-4687.
29. Romero, Roberto, Sonia S. Hassan, Pawel Gajer, Adi L. Tarca, Douglas W. Fadrosh, Lorraine Nikita, Marisa Galuppi et al. "The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women." Microbiome 2, no. 1 (2014): 1-19.
30. Shukla, Asmita, and J. D. Sobel. "Vulvovaginitis caused by Candida species following antibiotic exposure." Current infectious disease reports 21, no. 11 (2019): 1-6
31. Srinivasan, Sujatha, Congzhou Liu, Caroline M. Mitchell, Tina L. Fiedler, Katherine K. Thomas, Kathy J. Agnew, Jeanne M. Marrazzo, and David N. Fredricks. "Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis." PloS one 5, no. 4 (2010): e10197
32. Torcia, Maria Gabriella. "Interplay among vaginal microbiome, immune response and sexually transmitted viral infections." International journal of molecular sciences 20, no. 2 (2019): 266.
33. van de Wijgert, Janneke HHM, and Vicky Jespers. "The global health impact of vaginal dysbiosis." Research in microbiology 168, no. 9-10 (2017): 859-864.
34. Van Oostrum, Noortje, Petra De Sutter, Joris Meys, and Hans Verstraelen. "Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis." Human reproduction 28, no. 7 (2013): 1809-1815.
35. Walther-António, Marina RS, Jun Chen, Francesco Multinu, Alexis Hokenstad, Tammy J. Distad, E. Heidi Cheek, Gary L. Keeney et al. "Potential contribution of the uterine microbiome in the development of endometrial cancer." Genome medicine 8, no. 1 (2016): 1-15.
36. Wiesenfeld, Harold C., Sharon L. Hillier, Marijane A. Krohn, Daniel V. Landers, and Richard L. Sweet. "Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection." Clinical Infectious Diseases 36, no. 5 (2003): 663-668.
37. Yang, Xi, Miao Da, Wenyuan Zhang, Quan Qi, Chun Zhang, and Shuwen Han. "Role of Lactobacillus in cervical cancer." Cancer management and research 10 (2018): 1219.